Capital Asset Advisory Services’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-4,245
| Closed | -$267K | – | 713 |
|
|
2021
Q2 | $267K | Sell |
4,245
-222
| -5% | -$14K | 0.03% | 379 |
|
|
2021
Q1 | $415K | Sell |
4,467
-417
| -9% | -$38.7K | 0.06% | 286 |
|
|
2020
Q4 | $438K | Sell |
4,884
-174
| -3% | -$15.6K | 0.08% | 219 |
|
|
2020
Q3 | $523K | Sell |
5,058
-219
| -4% | -$22.6K | 0.11% | 151 |
|
|
2020
Q2 | $646K | Sell |
5,277
-682
| -11% | -$83.5K | 0.14% | 132 |
|
|
2020
Q1 | $484K | Sell |
5,959
-254
| -4% | -$20.6K | 0.13% | 135 |
|
|
2019
Q4 | $390K | Sell |
6,213
-416
| -6% | -$26.1K | 0.09% | 215 |
|
|
2019
Q3 | $347K | Buy |
6,629
+320
| +5% | +$16.8K | 0.23% | 78 |
|
|
2019
Q2 | $305K | Buy |
+6,309
| New | +$305K | 0.24% | 82 |
|
|
2019
Q1 | – | Sell |
-8,255
| Closed | -$489K | – | 83 |
|
|
2018
Q4 | $489K | Sell |
8,255
-453
| -5% | -$26.8K | 0.47% | 51 |
|
|
2018
Q3 | $573K | Buy |
8,708
+326
| +4% | +$21.5K | 0.48% | 48 |
|
|
2018
Q2 | $423K | Sell |
8,382
-1,441
| -15% | -$72.7K | 0.38% | 59 |
|
|
2018
Q1 | $517K | Sell |
9,823
-360
| -4% | -$18.9K | 0.48% | 52 |
|
|
2017
Q4 | $473K | Sell |
10,183
-2,138
| -17% | -$99.3K | 0.43% | 62 |
|
|
2017
Q3 | $498K | Sell |
12,321
-65
| -0.5% | -$2.63K | 0.45% | 56 |
|
|
2017
Q2 | $416K | Buy |
+12,386
| New | +$416K | 0.27% | 85 |
|